Gaudium IVF and Women Health Limited — PPTs, 29-05-2026: Investor Presentation

Here's a summary of Gaudium IVF's investor presentation:

**Business Performance:** Gaudium IVF reported strong consolidated revenue growth of 47.56% YoY to Rs. 10,435.70 lakh for FY26. This was driven by increased patient volumes across its established hubs, supported by high clinical success rates and operational efficiencies. EBITDA also saw a healthy increase of 31.69% YoY.

**Growth Drivers/Strategy:** The company is focused on leveraging its AI-powered end-to-end fertility solutions, including AI-driven sperm selection (SiD) and embryo assessment (ERICA), to enhance success rates and standardize outcomes. Expansion plans include launching 8 new centers by FY28, enhancing pan-India visibility and customer footfall.

**Recent Developments:** Gaudium IVF was the first Indian IVF company to list on the stock market, a significant strategic milestone. They are also a leader in adopting Artificial Intelligence in infertility treatment.

**Key Financial Metrics:** Consolidated revenue from operations stood at Rs. 10,435.70 lakh for FY26. Operating EBITDA was Rs. 3,770.40 lakh, and PAT (from continuing operations) was Rs. 2,448.85 lakh.

**Management Commentary/Outlook:** The company's rapid growth strategy, including new center launches, is expected to drive higher revenues and strengthen financial parameters. Gaudium IVF aims to solidify its position as a leading large player in the industry.